Patents by Inventor Betsy Herold

Betsy Herold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE
    Publication number: 20230293674
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: November 29, 2022
    Publication date: September 21, 2023
    Inventors: William Jacobs, JR., Betsy Herold, Joseph Dardick, Kayla A. Weiss
  • PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20220088185
    Abstract: Methods for passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such.
    Type: Application
    Filed: January 3, 2020
    Publication date: March 24, 2022
    Inventors: Betsy HEROLD, William JACOBS, JR., Pablo A. GONZALEZ-MUNOZ, Christopher PETRO
  • METHOD OF ENHANCING ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC)
    Publication number: 20210361743
    Abstract: Methods of preferentially enhancing in a subject an antibody-dependent cell-mediated cytotoxicity (ADCC) antibody response over a neutralizing antibody response to a vaccine for an infectious agent using herpesvirus entry mediator (HVEM) agonists, and related compositions.
    Type: Application
    Filed: October 17, 2019
    Publication date: November 25, 2021
    Inventors: Betsy HEROLD, Clare BURN
  • HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE
    Publication number: 20210236625
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 5, 2021
    Inventors: William Jacobs, Jr., Betsy Herold, Joseph Dardick, Kayla A. Weiss
  • Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 10980874
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: April 20, 2021
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
  • Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 10918712
    Abstract: Methods for passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: February 16, 2021
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: Betsy Herold, William Jacobs, Jr., Pablo A. Gonzalez-Munoz, Christopher Petro
  • RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20200376114
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: August 18, 2020
    Publication date: December 3, 2020
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
  • Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 10751411
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: August 25, 2020
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez Munoz, Betsy Herold, Christopher Petro
  • RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20200023058
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: July 30, 2019
    Publication date: January 23, 2020
    Inventors: William Jacobs, JR., Pablo A. Gonzalez Munoz, Betsy Herold, Christopher Petro
  • Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 10391165
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: August 27, 2019
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
  • PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20190240321
    Abstract: Methods for passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such.
    Type: Application
    Filed: January 3, 2019
    Publication date: August 8, 2019
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventor: Betsy Herold
  • RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20190111127
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: June 1, 2018
    Publication date: April 18, 2019
    Applicant: ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
    Inventors: William Jacobs, JR., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
  • Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 10076568
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: September 18, 2018
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez Munoz, Betsy Herold, Christopher Petro
  • Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
    Patent number: 9999665
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: June 19, 2018
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: William Jacobs, Jr., Pablo A. Gonzalez Munoz, Betsy Herold, Christopher Petro
  • RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20170202952
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: March 10, 2017
    Publication date: July 20, 2017
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
    Inventors: William Jacobs, JR., Pablo A. Gonzales Munoz, Betsy Herold, Christopher Petro
  • RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS
    Publication number: 20160158343
    Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 9, 2016
    Applicant: Albert Einstein College of Medicine, Inc.
    Inventors: William Jacobs, JR., Pablo A. Gonzalez Munoz, Betsy Herold, Christopher Petro
  • Method to treat or prevent herpesvirus infections
    Patent number: 9333219
    Abstract: Methods and compositions are provided for inhibiting or treating a herpesvirus infection in a subject using inhibitors of mammalian Akt.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: May 10, 2016
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: Betsy Herold, Natalia Cheshenko
  • METHOD TO TREAT OR PREVENT HERPESVIRUS INFECTIONS
    Publication number: 20150190419
    Abstract: Methods and compositions are provided for inhibiting or treating a herpesvirus infection in a subject using inhibitors of mammalian Akt.
    Type: Application
    Filed: July 25, 2013
    Publication date: July 9, 2015
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
    Inventors: Betsy Herold, Natalia Cheshenko
  • Sulfated molecular umbrellas as anti-HIV and anti-HSV agents
    Publication number: 20070232576
    Abstract: A chemical genus of sulfated cholestanes attached to an oligomer through amide or ester bonds is disclosed. The compounds are useful as anti human immunodeficiency virus (HIV) and anti-herpes simplex virus (HSV) agents. The compounds have the general formula in which CPS (the structure within the square brackets) is a cholanic acid derivative. R1 to R16 are chosen independently from H, OH and OSO3?A+. W is a direct bond or a deshydrogen residue of a C3-C6 diol or triol. A is chosen from H+, a quaternary ammonium species and the cation of an alkali or alkaline earth metal. Z is a direct bond or a residue of an amino acid, a peptide or an aminosulfonic acid. ? is a moiety having n or more —NH and —OH groups separated by 6 or fewer carbons; and n is an integer from 6 to 200.
    Type: Application
    Filed: September 20, 2005
    Publication date: October 4, 2007
    Applicants: Lehigh University, Mount Sinai School of Medicine of New York University
    Inventors: Steven Regen, Betsy Herold